Eli Lilly and Co said on Tuesday it is considering the sale of its Elanco animal health business and expressed optimism that its rejected rheumatoid arthritis drug would pass muster with U.S. regulators when it resubmits its application. * Eli …
Volkswagen’s new CC-replacement, the Arteon, is very nice. I just hate what it makes my mouth do. Specifically, I dislike saying its name. Volks-wag-en Ar-te-on. How does a word with six letters have the same amount of syllables as a word …
Spread across three weekends over three cities in Peninsular Malaysia, the “Your Whee-lly Fun Day” roadshow kicked off at Juru Auto City, Penang last weekend and will head to 1 Utama (this weekend, May 13-14) and Angsana Mall JB …
Toward the end of my phone call, Mr. Barofsky said it himself: “The government had no choice but to bail out A.I.G.” Then he added that Treasury’s sale of A.I.G. stock “is unambiguously good news for the country.”
And business is booming for one of America's most vaunted brands in the pharmaceutical sector. Since Jan. 1, the quote for JNJ stock has risen from $113 to $136 per share, and is up 15.4 percent on a 52-week basis. Yet some Wall Street …
Credit Suisse says ** About 1.7 mln LLY shares traded vs 25-day moving avg of 3.7 mln ** Lilly has reported disappointing data on Alzheimer’s medicine in Nov and on last week said FDA declined to approve its arthritis drug ** Investors are …
Hancock Holding (NASDAQ:HBHC): Bank of America-Merrill Lynch launches the stock at Underperform. Ruby Tuesday (NYSE:RT): The company is assigned a Buy recommendation and $10 target at B. Riley & Co., which has high hopes …
Nobody wants to be the general manager of the New York Jets. This is weird. "They can't give the position away," Fox Sports insider and NFL Network contributor Jay Glazer reported Sunday. "They are now calling back candidates that …
NFL4y
Why don’t we have an Alzheimer’s drug yet? Quartz reported previously: There are many reasons for our lack of success. First, we’ve only really understood what Alzheimer’s is in the last 20 years, after we developed the technology to probe …
INDIANAPOLIS (AP) — Eli Lilly is weighing the sale of an animal health business that the drugmaker once touted as key in helping it overcome the loss of patent protection for some top-selling drugs. Lilly said Tuesday that alternatives for its …